Kidney Function Test in Johor Bahru

Most organs complain when they are injured. Kidneys do not. There is no pain fibre in the filtering tissue, nothing to tell you something is going wrong. Chronic kidney disease progresses through years of a life in complete quiet, and that quiet is not reassurance — it is the central difficulty in managing the condition. The reason lies in reserve. You are born with far more filtering capacity than daily life requires, spread across roughly a million filtering units in each kidney. When some are destroyed, the rest work harder and take up the load. The body compensates so effectively that a person can lose a very large share of total kidney function and still feel entirely well, still work a full shift, still pass a normal volume of urine each day. Waiting for symptoms therefore means waiting for that compensation to run out. When symptoms finally arrive, they are these: persistent tiredness that sleep does not fix, poor appetite, nausea, itching with no rash to explain it, swelling of the ankles and around the eyes, breathlessness on mild exertion or lying flat, waking repeatedly at night to pass urine, and the pallor and exhaustion of anaemia as the kidneys stop producing enough of the hormone that drives red cell production. Every one of those is a late feature. By the time they appear, scarring is usually established, and scarred kidney tissue does not regenerate. Treatment then slows decline; it does not reverse it. This is precisely why kidney testing is done in people who feel completely well. It is not a search for an explanation of symptoms. It is a search for a process already running that has not yet announced itself, in the window where the outcome can still be changed.

The blood test almost everyone has had is serum creatinine, a waste product generated at a fairly steady rate by muscle metabolism, released into the blood and cleared by the kidneys into the urine. If the kidneys clear less of it, the blood level rises. That logic is sound, and creatinine remains useful. But it has two weaknesses that matter enormously in practice, and both cause missed disease. The first is muscle mass. Because creatinine comes from muscle, how much you produce depends on how much muscle you carry. A twenty-five year old man who lifts weights produces a great deal of it, and his blood level may sit at the upper end of the reference range with entirely normal kidneys. A thin seventy year old woman of small build produces very little, and her level may sit comfortably within range while a substantial share of her kidney function has gone. Two people, an identical number on the report, completely different kidneys. The second weakness is timing. The relationship between creatinine and filtration is not a straight line. Creatinine stays close to normal while the surviving filtering units compensate, and climbs clearly only once that compensation is exhausted. Meaningful function can be lost before the number moves out of the laboratory's normal range at all. The practical conclusion is not to abandon creatinine but to stop reading a result inside the normal range as proof that the kidneys are healthy. On its own it is a blunt instrument that reports late. It needs converting into something more interpretable, and it needs a second, very different test alongside it.

The estimated glomerular filtration rate, or eGFR, is what makes a creatinine result usable. It adjusts the creatinine value using your age and sex, producing an estimate of how many millilitres of blood your kidneys clear per minute. Instead of a raw concentration that means different things in different bodies, you get a single number on a scale where roughly 90 and above is normal and lower numbers indicate less function. In outline, an eGFR of 90 or above with no other evidence of damage is normal. Between 60 and 89 is a mild reduction, which alone, without albuminuria or structural abnormality, is often not classified as disease, particularly in older adults. Between 45 and 59, and again between 30 and 44, describes moderate reduction, the range where complications accumulate quietly — anaemia, disturbances of calcium and phosphate, rising blood pressure — and where medication doses often need adjusting. Between 15 and 29 is severe reduction requiring specialist involvement. Below 15 is kidney failure, the stage at which dialysis or transplantation is discussed. One point deserves emphasis. A single low eGFR is not a diagnosis of chronic kidney disease. The word chronic carries a specific requirement: the abnormality must persist for at least three months. A one-off reduced result is extremely common during dehydration, during a feverish illness, after vomiting or diarrhoea, after a long day outdoors in Johor's heat, or while taking certain medicines, and function frequently recovers once the cause resolves. So an abnormal eGFR leads to a repeat test after an interval, taken when you are well and properly hydrated, and interpreted alongside your urine result. The direction of travel across several results tells us far more than any single figure.

A renal profile reports urea alongside creatinine, together with electrolytes. Each has to be read for what it actually measures. Urea is a waste product of protein breakdown, produced in the liver and excreted by the kidneys. It rises in kidney impairment, but it is far less specific than creatinine because so many other things move it. Dehydration raises urea sharply, since urea is reabsorbed along with water when the body is conserving fluid. A high protein diet raises it. Bleeding into the gastrointestinal tract raises it, because the blood is digested as protein. Certain drugs raise it. A raised urea with a normal creatinine most often points to dehydration rather than kidney disease. Sodium reflects the balance of water and salt rather than filtration itself, and abnormal values usually point to fluid balance problems, diuretics, or hormonal causes. Potassium matters most in immediate practical terms. Healthy kidneys excrete the potassium you consume; as function declines, that excretion becomes less reliable and potassium accumulates in the blood. High potassium interferes with the electrical activity of the heart and can cause dangerous rhythm disturbances, including rhythms that stop the heart. It usually produces no symptoms beforehand, or nothing more than vague weakness, which is why it is checked rather than waited for. Two everyday things make this worse. Several common medicines raise potassium, including certain blood pressure drugs used in kidney and heart disease, some diuretics, and anti-inflammatory painkillers. And the low-sodium salts and salt substitutes sold as the healthier choice generally replace sodium with potassium chloride. Someone with reduced kidney function who switches believing they are protecting their heart may be doing the opposite. In more advanced disease the panel widens to calcium, phosphate and bicarbonate. Phosphate rises and calcium falls as the kidneys lose the ability to activate vitamin D, disturbing bone metabolism, and bicarbonate falls as acid builds up.

If you take one thing from this page, take this. The single most useful kidney test for most people is not a blood test at all. It is a urine test, the albumin-to-creatinine ratio, usually written as ACR, and it is routinely omitted. Albumin is the main protein in blood. The filtering barrier in a healthy kidney is highly selective and keeps albumin in the circulation, so almost none reaches the urine. When that barrier is damaged — by the small vessel injury of diabetes, by the pressure of hypertension, by inflammation of the filtering units — albumin leaks through. Detecting that leak is detecting damage directly, rather than inferring it from waste products that have accumulated because filtration has already fallen. The timing is the point. Albuminuria appears years before creatinine rises and eGFR falls. In diabetic kidney disease the sequence is well established: the leak comes first, the loss of filtration follows. A person can have a normal creatinine, a normal eGFR and a clearly raised ACR — and that person has kidney disease, at exactly the stage where intervention works best. It is also easy. It needs a single urine sample, ideally the first of the morning. No timed collection, no twenty-four hour jug, no fasting. The laboratory reports the ratio of albumin to creatinine, which corrects for how dilute the urine is. Broadly, below 3 mg/mmol is normal, 3 to 30 mg/mmol is moderately increased albuminuria, and above 30 mg/mmol is severely increased. Now the part that causes the most missed disease. The ordinary urine dipstick, the strip with coloured pads used in almost every clinic, tests for protein and is far less sensitive than ACR. It generally will not turn positive until protein loss is well beyond the early range. A negative dipstick is not evidence that your kidneys are fine. People are reassured by that result every day, and some of them have albuminuria an ACR would have found. ACR is also more than a diagnostic marker. The degree of albuminuria independently predicts how fast kidney function will decline, and predicts heart attack, stroke and cardiovascular death, even where eGFR is normal. Despite all of this, it is under-used. People with diabetes and people with hypertension should have an ACR at least once a year, and a great many have never had one, having been told for years that their kidney blood test was normal. If you have diabetes or high blood pressure and cannot recall giving a urine sample for this test, ask for it. Two practical caveats. A raised ACR should be confirmed on a repeat sample, because fever, heavy exercise the day before, urinary infection and menstruation can all raise it transiently; two abnormal results out of three over roughly three months establishes persistent albuminuria. And finding it genuinely changes treatment: blood pressure targets become tighter, medication shifts towards agents that reduce albuminuria and protect the kidney rather than merely lowering the number, glucose management is revisited, and cardiovascular risk is treated more aggressively. The result does not sit on a file. It redirects care.

Malaysia has one of the largest and fastest-growing dialysis populations in the world relative to its size. The number of Malaysians starting renal replacement therapy each year has climbed steeply over recent decades, dialysis centres have multiplied across the country including throughout Johor, and the cost to families and the health system is severe. The causes are not mysterious. Diabetes accounts for roughly half of all new patients starting dialysis, with hypertension responsible for a further large share. Between them, two conditions diagnosable in a ten minute consultation and treatable with widely available medicines account for most kidney failure here. That composition is what makes this an avoidable epidemic. Diabetic and hypertensive kidney disease does not appear overnight. It develops across ten, fifteen, twenty years, passing through a long phase of albuminuria with preserved filtration in which the person feels entirely normal and the trajectory can still be bent. Blood pressure control, glucose control, the right choice of medication, avoiding kidney-toxic exposures and regular monitoring genuinely slow progression, and for some people change the destination altogether. The uncomfortable implication is that prevention has to happen at the stage where nothing is wrong from the patient's point of view. The person who avoids dialysis at sixty-five is usually the one who, at forty-five, gave a urine sample they did not think they needed and adjusted their treatment on the strength of it. We run over sixty blood tests on site at Klinik Muhibbah, and kidney testing sits at the centre of the chronic disease monitoring we do here. To find out what an assessment would involve for you, call +60 7-251 1162 or WhatsApp +60 17-500 7205 and we will go through what is included and what it costs.

A meaningful share of kidney damage in Malaysia comes from exposures people choose, usually without any idea the kidney is involved. Non-steroidal anti-inflammatory painkillers head the list. Ibuprofen, diclofenac, mefenamic acid and naproxen are effective drugs, widely available over the counter, taken for knee pain, back pain, headache and period pain by enormous numbers of people, often for years. They work partly by constricting the small arteries supplying the filtering units, reducing blood flow through the kidney. A short course in a well-hydrated person is generally tolerated. Regular or high-dose use over long periods causes cumulative damage, and the risk rises sharply when you are dehydrated, when you are already on blood pressure medication of certain classes, and when kidney function is already reduced. If you find yourself buying these tablets month after month, the underlying pain problem needs assessment rather than indefinite self-treatment. Unregistered traditional, herbal and slimming products are the second major avoidable cause. Malaysia has seen repeated episodes of kidney injury traced to products adulterated with undeclared pharmaceutical ingredients — steroids, painkillers, diuretics — and to products contaminated with heavy metals such as lead, mercury and arsenic. Slimming preparations, stamina products, joint remedies and detox regimens sold through social media, online marketplaces and unlicensed sellers are the recurring offenders. Natural does not mean safe. Check that any product carries a valid registration with the national medicines regulator, verifying the number rather than trusting the packaging, and tell your doctor about everything you take, including supplements, traditional medicines and tonics — people routinely omit these because they do not consider them medicines. The remaining causes are more familiar but no less important. Repeated urinary tract infections that are not properly treated can scar the kidney over time. Kidney stones cause obstruction and recurrent infection and damage tissue silently when they sit undetected. Hypertension diagnosed but never controlled to target, and diabetes with persistently high glucose, do their damage steadily regardless of how well the person feels. Contrast agents used in CT scanning carry a risk of kidney injury in people whose function is already reduced, which is one reason your kidney results matter before a scan is arranged.

Testing is worthwhile wherever the chance of finding something is meaningful, which includes many people who feel perfectly well. Everyone with diabetes should have kidney function and an ACR at least annually, and everyone with hypertension the same. People with established cardiovascular disease should be tested, since kidney and cardiovascular disease travel together, as should anyone with a family history of kidney disease. People with gout, people on long-term medications affecting the kidneys, and people with recurrent stones or urinary infections all warrant testing, as do older adults as part of general screening. If you are a Malaysian aged 40 or above and eligible under PEKA B40, screening is available here at no cost to you. When results are abnormal, the shape of management is fairly consistent. Blood pressure is brought to a target usually tighter than for people without kidney disease, and the medication chosen for its kidney-protective effect rather than only for the number it produces. Glucose control is optimised in diabetes. Every medicine you take is reviewed, with nephrotoxic drugs stopped where possible and doses of renally cleared drugs adjusted to your eGFR. Dietary advice covers salt, and protein and potassium where the stage warrants it. Cardiovascular risk is treated actively, because people with kidney disease are far more likely to die of heart disease than to reach dialysis. You will be advised to avoid dehydration, which is not trivial advice in Johor's heat and matters particularly during fasting and outdoor work. Vaccination is reviewed, since infection risk is higher. And monitoring intervals are set by stage, from annually in mild disease to several times a year as function declines. Referral to a nephrologist follows a substantially reduced eGFR, function declining rapidly across serial tests, heavy albuminuria, persistent haematuria, blood pressure uncontrolled despite several agents, suspected inherited kidney disease, or electrolyte disturbances that are difficult to manage. Klinik Muhibbah tests, monitors and manages the risk factors that drive kidney disease, and refers onward for the nephrology care, biopsy and dialysis it does not provide. Some situations should not wait for an appointment. Passing very little or no urine, visible blood in the urine, sudden severe swelling of the legs or face, breathlessness lying flat, or confusion and drowsiness in someone with known kidney impairment all need immediate assessment. Go to the nearest emergency department or call 999. For everything else, we are at No. 62 Jalan Kiambang, Taman Bunga Raya, 81700 Masai, Johor, open Monday to Thursday and Saturday 9AM to 9PM, Friday 9AM to 3PM and Sunday 9AM to 1PM, with Dr. Prabagaran Kanapathy and Dr. Kirubah Sai Patnaik. Blood testing, ECG, ultrasound and X-ray are on site, so an assessment is usually finished in one visit. Book at movo-x.com/kiosk/muhibbah, or use teleconsultation at RM30 prepaid to discuss results you already have, with medication delivery within Johor state. This page is general health information and does not replace an individual consultation.